F.D.A. Panel Endorses Pfizer-BioNTech Vaccine for Children 5 to 11


A key advisory committee to the Food and Drug Administration voted overwhelmingly to recommend the use of Pfizer-BioNTech’s coronavirus vaccine in 5- to 11-year-olds, bringing the vaccine a big step closer to about 28 million children. Shots could be offered as early as next week.

For More, Click HERE


Sponsored Content

Sponsored Content